| Not Yet Recruiting | A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in NCT07498725 | LARKSPUR BIOSCIENCES, INC. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event NCT07499128 | National Cancer Institute (NCI) | N/A |
| Not Yet Recruiting | A Study of JNJ-1761981 in Participants With Solid Tumors NCT07525141 | Johnson & Johnson Enterprise Innovation Inc. | Phase 1 |
| Recruiting | First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in NCT07438782 | GlaxoSmithKline | Phase 1 |
| Not Yet Recruiting | Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice NCT07501780 | Maastricht University Medical Center | — |
| Not Yet Recruiting | An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga- NCT07420036 | Zhongnan Hospital | EARLY_Phase 1 |
| Recruiting | An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therap NCT07469683 | Yonsei University | Phase 2 |
| Recruiting | Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms NCT07382817 | M.D. Anderson Cancer Center | Phase 1 |
| Not Yet Recruiting | IMMUNO-FIT Observational Study NCT07354971 | University Hospital Southampton NHS Foundation Trust | — |
| Recruiting | Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies NCT07276373 | Corcept Therapeutics | Phase 1 / Phase 2 |
| Not Yet Recruiting | Fertility Outcomes of Ovarian Tissue Cryopreservation NCT07339995 | Chinese University of Hong Kong | — |
| Not Yet Recruiting | Finding My Way-UK: Promoting Positive Psychological Outcomes in People Living With and Beyond Curatively Treat NCT07356726 | Edge Hill University | N/A |
| Recruiting | A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer NCT07258836 | Eli Lilly and Company | Phase 1 |
| Recruiting | A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced NCT07277270 | GlaxoSmithKline | Phase 1 |
| Recruiting | IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia NCT07257640 | Zhejiang University | Phase 1 |
| Recruiting | A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With C NCT07169851 | Eli Lilly and Company | Phase 2 |
| Recruiting | ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted NCT07191730 | University Hospital, Caen | — |
| Recruiting | A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other An NCT07213609 | GlaxoSmithKline | Phase 1 / Phase 2 |
| Not Yet Recruiting | Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital NCT07206914 | Centre Hospitalier de Saint-Denis | — |
| Recruiting | Manual Lymph Drainage for External Lymphedema NCT07215169 | Lund University | N/A |
| Enrolling By Invitation | Implementing VTE Prevention in Ambulatory Cancer Care NCT07292376 | University of Vermont | N/A |
| Withdrawn | HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma NCT04482933 | Pediatric Brain Tumor Consortium | Phase 2 |
| Recruiting | Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy NCT07073807 | University of California, Irvine | N/A |
| Recruiting | Physical Activity in Cancer Patients in an Oncology Day Clinic - Implementing a Person-centered Program Led by NCT06999616 | St.Gallen University of Applied Sciences | — |
| Active Not Recruiting | A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations NCT07038369 | Atavistik Bio, Inc | Phase 1 |
| Withdrawn | Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors NCT06161558 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumo NCT06885697 | National Cancer Institute (NCI) | Phase 1 |
| Not Yet Recruiting | A Study to Evaluate the Effectiveness of a Web-based Tool for Fertility Preservation in Cancer Patients NCT07038174 | National Cancer Center, Korea | N/A |
| Not Yet Recruiting | Determinants of Physical Activity Level in Pediatric Oncological Patients Treated With Cardiotoxic Therapy - a NCT06256068 | Medical University of Warsaw | — |
| Not Yet Recruiting | Abscopal Effect from Low-dose Radiotherapy in Metastatic Cancer Combined with Stereotactic Body Radiotherapy NCT05578274 | Soonchunhyang University Hospital | N/A |
| Recruiting | Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors NCT06902350 | Chipscreen Biosciences, Ltd. | Phase 1 |
| Recruiting | Involvement of the Immune System in Intrinsic Radiosensitivity NCT06826066 | Assistance Publique - Hôpitaux de Paris | N/A |
| Recruiting | Impact of Free Mobility on FDG Uptake in PET Scans NCT06799819 | Centre Hospitalier Régional d'Orléans | N/A |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO767 NCT06884618 | Hoffmann-La Roche | Phase 1 |
| Completed | Silent Threat: Impact of Preoperative Albumin Levels on Outcomes in Geriatric Cancer Surgery NCT06998030 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | — |
| Recruiting | A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid NCT06687941 | Aptamer Sciences, Inc. | Phase 1 |
| Active Not Recruiting | A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People Wi NCT06967155 | Blokhin's Russian Cancer Research Center | Phase 2 |
| Recruiting | A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metas NCT06978400 | Blokhin's Russian Cancer Research Center | Phase 2 |
| Recruiting | Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 NCT06785636 | Pathos AI, Inc. | Phase 1 / Phase 2 |
| Recruiting | Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients NCT07200453 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Recruiting | Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial NCT06756061 | Byung-Sik Cho | Phase 2 |
| Not Yet Recruiting | Exercise for Fighting Oncology Repercussions After Treatment NCT05980325 | Universitat Pompeu Fabra | N/A |
| Recruiting | E-CANE: a National Program of Remote Health Education Workshops NCT06748820 | Centre Hospitalier Universitaire de Nice | — |
| Enrolling By Invitation | A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring NCT06788509 | Janssen Research & Development, LLC | Phase 1 |
| Recruiting | Screening Strategies Among High-risk Populations for Anal Cancer NCT06628570 | Lisa Flowers | N/A |
| Recruiting | 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prost NCT06706921 | VA Greater Los Angeles Healthcare System | Phase 4 |
| Enrolling By Invitation | A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Ter NCT06709040 | Novo Nordisk A/S | — |
| Recruiting | CD70-targeted immunoPET Imaging of Kidney Cancer NCT06680089 | RenJi Hospital | Phase 2 |
| Active Not Recruiting | Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study NCT06494241 | AstraZeneca | — |
| Recruiting | A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without NCT06496971 | NaviFUS Corporation | Phase 3 |
| Recruiting | Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue NCT06482515 | University of Maryland, Baltimore | Phase 2 |
| Recruiting | Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors NCT06819215 | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblast NCT06329570 | NaviFUS Corporation | Phase 1 / Phase 2 |
| Recruiting | Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older. NCT06717581 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA) NCT06884878 | National Cancer Institute, Naples | — |
| Completed | Impact of Pharmacy Services on Gynaecology Chemotherapy Safety NCT06826950 | Peking University First Hospital | — |
| Recruiting | A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101) NCT06551142 | GlaxoSmithKline | Phase 1 |
| Terminated | A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With NCT06546553 | Pfizer | Phase 1 |
| Active Not Recruiting | Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine NCT06670560 | Zhou Chengzhi | — |
| Recruiting | Current Awareness, Perspective and Knowledge on Social Egg Freezing NCT06581666 | Chinese University of Hong Kong | — |
| Recruiting | Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma NCT06676527 | Jinling Hospital, China | — |
| Recruiting | Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Se NCT07035587 | Yonsei University | — |
| Recruiting | Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients (HKCH) NCT06505057 | Chinese University of Hong Kong | N/A |
| Completed | Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets a NCT06444477 | University Hospital, Bordeaux | — |
| Withdrawn | Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as A NCT05898828 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC NCT06376084 | AstraZeneca | — |
| Terminated | A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Nor NCT05209295 | Bristol-Myers Squibb | Phase 1 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injecti NCT06431594 | GlaxoSmithKline | Phase 1 |
| Recruiting | Early Intervention Strategies for Lung Cancer NCT06988943 | The First Affiliated Hospital of Guangzhou Medical University | N/A |
| Not Yet Recruiting | A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer NCT06341283 | The Affiliated Hospital of Qingdao University | — |
| Recruiting | Prehab for Lung and Esophageal Cancer NCT06354959 | Nova Scotia Health Authority | N/A |
| Recruiting | Endometrial Cell Collection With the PadKit NCT06464107 | Hackensack Meridian Health | N/A |
| Recruiting | PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression NCT06289517 | Peking University First Hospital | N/A |
| Completed | Eat, Play, Sleep: A Text Message Approach to Promoting Health Behaviors for Cancer Survivors and Their Caregiv NCT06234267 | University of Arizona | N/A |
| Completed | Nurse-Led Electronic Patient-Reported Outcome System to Improve Quality of Life in Chemotherapy Patients NCT07144449 | CHIAO-CHI KUAN | N/A |
| Completed | Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia NCT06170385 | University of Alberta | N/A |
| Recruiting | Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors NCT06346041 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | EARLY_Phase 1 |
| Recruiting | A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors NCT06311578 | Johnson & Johnson Enterprise Innovation Inc. | Phase 1 |
| Recruiting | A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study NCT06271252 | OriCell Therapeutics Co., Ltd. | Phase 1 |
| Completed | BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE NCT06247865 | Portsmouth Hospitals NHS Trust | — |
| Unknown | Increasing Physical Activity Through Personalised Motivational Messaging to Improve Cognitive Function in Lung NCT06003335 | The University of Hong Kong | N/A |
| Recruiting | Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal C NCT06365866 | Taipei Veterans General Hospital, Taiwan | N/A |
| Recruiting | Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab NCT06237920 | The Netherlands Cancer Institute | Phase 2 |
| Recruiting | A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting NCT05836896 | Technische Universität Dresden | Phase 1 |
| Recruiting | Personalized Live-remote Exercise Training for Cancer Survivors NCT06270628 | UMC Utrecht | N/A |
| Terminated | A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors NCT06285097 | Pfizer | Phase 1 |
| Recruiting | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy NCT06362070 | Azienda Ospedaliera Universitaria Integrata Verona | N/A |
| Recruiting | Evaluation of a Program for Routine Implementation of Symptom Distress Screening and Referral in Cancer Care NCT05949996 | The University of Hong Kong | N/A |
| Unknown | Feasibility of an Advance Care Planning Intervention NCT06149312 | Institut de cancérologie Strasbourg Europe | N/A |
| Recruiting | Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG) NCT06044441 | National Cancer Centre, Singapore | N/A |
| Recruiting | A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms NCT06150157 | Janssen Research & Development, LLC | Phase 1 |
| Recruiting | A Study of JNJ-87890387 for Advanced Solid Tumors NCT06178614 | Janssen Research & Development, LLC | Phase 1 |
| Recruiting | A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-S NCT06177925 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Recruiting | Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors NCT06203574 | Huashan Hospital | N/A |
| Recruiting | Anatomical-Clinical Base of Adenocarcinoma Pancreatic NCT06128343 | University Hospital, Toulouse | — |
| Recruiting | c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration NCT05882292 | Yonsei University | Phase 2 |
| Recruiting | Biennial CEM in Women With a Personal History of Breast Cancer NCT06105749 | Wendie Berg | N/A |
| Active Not Recruiting | Hispanic Adapted and Culturally Relevant Exercising Together NCT06018311 | University of Arizona | N/A |
| Recruiting | Resilience in East Asian Immigrants for Advance Care Planning Discussions NCT06035549 | University of Illinois at Chicago | — |
| Active Not Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of NCT06077877 | GlaxoSmithKline | Phase 1 / Phase 2 |
| Completed | Physical Activity and Healthy Eating Among Young Adult Cancer Survivors NCT05887401 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Unknown | Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) NCT06005259 | University of Sao Paulo | Phase 4 |
| Recruiting | Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma NCT05964101 | The First Affiliated Hospital of Guangzhou Medical University | Phase 2 |
| Withdrawn | Omics of Cancer: OncoGenomics NCT05431439 | National Cancer Institute (NCI) | — |
| Recruiting | Real World Registry for Use of the Ion Endoluminal System NCT06004440 | Intuitive Surgical | — |
| Unknown | Individual Food Preferences for the Mediterranean Diet in Cancer Patients NCT06058312 | Centre Antoine Lacassagne | N/A |
| Not Yet Recruiting | Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomar NCT05834426 | Sociedad de Lucha Contra el Cáncer del Ecuador | — |
| Unknown | ACS Community Access to Resources Education and Support NCT06285929 | American Cancer Society, Inc. | — |
| Unknown | Noninvasive Internal Jugular Venous Oximetry NCT06004466 | National Taiwan University Hospital | — |
| Recruiting | An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced Cancer NCT06287294 | Our Lady's Hospice and Care Services | — |
| Unknown | Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC NCT05272865 | LaSanta S A S | Phase 1 / Phase 2 |
| Terminated | Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 NCT05980416 | Elevation Oncology | Phase 1 |
| Completed | Increasing Patient Comfort in Palliative Radiotherapy With a Newly Developed Mattress - A Prospective Clinical NCT06903507 | Erasmus Medical Center | N/A |
| Active Not Recruiting | Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) NCT05797246 | National Cancer Institute (NCI) | Phase 2 |
| Completed | The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland NCT06187350 | Ostergotland County Council, Sweden | — |
| Recruiting | Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients NCT05830929 | Chinese University of Hong Kong | N/A |
| Terminated | Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccR NCT05935748 | NiKang Therapeutics, Inc. | Phase 2 |
| Unknown | Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions NCT05907551 | Institut de cancérologie Strasbourg Europe | — |
| Recruiting | A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, NCT05573802 | Hellenic Society of Hematology | Phase 1 / Phase 2 |
| Recruiting | HTL0039732 in Participants With Advanced Solid Tumours NCT05944237 | Cancer Research UK | Phase 1 / Phase 2 |
| Unknown | PRediction Of Five Usual Tumors Using Blood Test for Risk Assessment and Early Detection NCT05874648 | Sixth Affiliated Hospital, Sun Yat-sen University | — |
| Recruiting | Serious Gaming for Chemotherapy-induced Nausea and Vomiting NCT05838638 | University of Central Florida | N/A |
| Withdrawn | Study to Identify and Measure the Values and Palliative Care Pref. of Hindu Patients and Their Caregivers NCT05538481 | Wake Forest University Health Sciences | — |
| Recruiting | 68Ga-P3 PET/CT Imaging in Prostate NCT05940259 | Peking University First Hospital | N/A |
| Active Not Recruiting | Deep sequencIng in Cutaneous Squamous CEll caRciNomas NCT05878288 | Peter MacCallum Cancer Centre, Australia | Phase 2 |
| Recruiting | 68Ga-P3 PET/CT Imaging in Malignancy NCT05887687 | Peking University First Hospital | N/A |
| Unknown | Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens NCT05704894 | Blau Farmaceutica S.A. | Phase 3 |
| Recruiting | Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix NCT05919758 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Recruiting | CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases NCT05827835 | Zhejiang University | Phase 1 / Phase 2 |
| Completed | RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL NCT05902845 | Xiaoyu Zhu | EARLY_Phase 1 |
| Unknown | A Study of TY-1091 in Patients With Advanced Solid Tumors NCT05675605 | TYK Medicines, Inc | Phase 1 / Phase 2 |
| Recruiting | The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia NCT06236373 | University of Modena and Reggio Emilia | — |
| Recruiting | A Self-management Based Survivorship Intervention for Chinese Cancer Survivors NCT05534386 | The University of Hong Kong | N/A |
| Unknown | Oral Nutritional Supplement Preferences in Patients With Cancer NCT05816369 | University of Bergen | N/A |
| Unknown | 18F-FAPI-RGD PET/CT in Various Tumor Types NCT06094530 | Sichuan Provincial People's Hospital | — |
| Recruiting | Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC) NCT05667766 | Murdoch Childrens Research Institute | N/A |
| Completed | Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiat NCT05895994 | MEI HENG | EARLY_Phase 1 |
| Completed | Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster O NCT05907603 | Kai Lin Xu，MD | EARLY_Phase 1 |
| Completed | Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy NCT05745909 | Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan | N/A |
| Withdrawn | Online Cancer-Related Fatigue Management NCT05017597 | Eastern Kentucky University | N/A |
| Active Not Recruiting | Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation NCT04711109 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL NCT05716113 | He Huang | EARLY_Phase 1 |
| Completed | Beat to Beat A Study in Paediatric, Adolescent and Young Adult Patients Who Are Undergoing or Have Undergone C NCT05615376 | Murdoch Childrens Research Institute | N/A |
| Recruiting | Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors NCT05391217 | Cedars-Sinai Medical Center | — |
| Active Not Recruiting | Time-Restricted Eating to Address Persistent Cancer-Related Fatigue NCT05256888 | University of Maryland, Baltimore | N/A |
| Completed | Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer NCT05712889 | Vincerx Pharma, Inc. | Phase 1 |
| Recruiting | Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture NCT05440240 | Regionshospitalet Silkeborg | Phase 4 |
| Recruiting | A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Part NCT05592626 | Marengo Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Abscopal Effect from the Low-dose Radiotherapy in Polymetastatic Cancer Patients Receiving Stereotactic Radiot NCT05733156 | Soonchunhyang University Hospital | N/A |
| Unknown | STABLE (Strength Training and Balance Leg Exercise) Study NCT04518098 | University of Saskatchewan | N/A |
| Unknown | Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06175780 | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | Phase 1 |
| Unknown | Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism NCT05729464 | Yongsheng Jiang | — |
| Completed | Sensitivity and Specificity of the Clinical Classifications Generated by the Cureety Digital Telemonitoring To NCT05653609 | Cureety | — |
| Recruiting | Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Canc NCT05574647 | Imperial College London | N/A |
| Not Yet Recruiting | A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma NCT05581875 | Hellenic Society of Hematology | Phase 1 / Phase 2 |
| Unknown | Effects of a Web Based Education Programme About Sexuality Aimed at Nurses That Care for Patients With Cancer NCT05573503 | Karlstad University | N/A |
| Completed | Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic NCT05514444 | Merck Sharp & Dohme LLC | Phase 1 |
| Unknown | COMPANION: A Couple Intervention Targeting Cancer-related Fatigue NCT05636696 | Mariët Hagedoorn | N/A |
| Recruiting | Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer NCT05386108 | Stemline Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | 68Ga-N188 PET/CT Imaging in Malignancy NCT05593107 | Peking University First Hospital | N/A |
| Completed | A Feasibility Study to Determine Whether the Botanical Garden Become a Region of Forest Therapy for Cancer Sur NCT06001723 | Taipei City Hospital | N/A |
| Unknown | Multi-modality Evaluation of Flow Rate, Pressure and Size of Spine Epidural Venous Plexus NCT05519618 | National Taiwan University Hospital | — |
| Completed | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors NCT05131815 | Cedars-Sinai Medical Center | N/A |
| Completed | ABSK021 Food Effect Study in Healthy Subjects NCT05280483 | Abbisko Therapeutics Co, Ltd | Phase 1 |
| Unknown | Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV. NCT05755659 | Xijing Hospital | N/A |
| Completed | The Families Addressing Cancer Together Intervention for Parents With Cancer NCT05377749 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Completed | CD155 Expression in Acute Myeloid Leukemia NCT06369662 | Assiut University | — |
| Completed | Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer NCT05235750 | University of Arkansas | N/A |
| Completed | Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate NCT05347979 | Corcept Therapeutics | Phase 1 |
| Unknown | Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality NCT05918536 | Regina Elena Cancer Institute | — |
| Recruiting | Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms NCT05475106 | Instituto de Medicina Regenerativa | EARLY_Phase 1 |
| Active Not Recruiting | Lymphaticovenous Anastomosis as Treatment for Lymphedema NCT05441943 | Odense University Hospital | N/A |
| Recruiting | Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts NCT05442151 | Tadashi Watabe | N/A |
| Unknown | A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received O NCT05298683 | Hellenic Society of Hematology | Phase 2 |
| Unknown | AI Guidance for Biopsy in Suspected Cholangiocarcinoma NCT05374122 | Instituto Ecuatoriano de Enfermedades Digestivas | N/A |
| Unknown | EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRP NCT05150236 | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Phase 2 |
| Unknown | A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma NCT05280275 | Hellenic Society of Hematology | Phase 1 / Phase 2 |
| Recruiting | OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. NCT04493632 | OncoSil Medical Limited | — |
| Unknown | Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging NCT04721756 | Avid Radiopharmaceuticals | EARLY_Phase 1 |
| Recruiting | Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms NCT05307367 | University of Copenhagen | N/A |
| Unknown | A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by I NCT05147493 | Hellenic Society of Hematology | Phase 2 |
| Completed | Retrospective Analysis of Colorectal Cancer Screening Results NCT05374369 | Creative Biosciences (Guangzhou) Co., Ltd. | — |
| Active Not Recruiting | First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors NCT05277051 | GlaxoSmithKline | Phase 1 |
| Terminated | (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations NCT05241873 | Blueprint Medicines Corporation | Phase 1 |
| Active Not Recruiting | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in T NCT05103358 | Aadi Bioscience, Inc. | Phase 2 |
| Terminated | (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC NCT05153408 | Blueprint Medicines Corporation | Phase 1 |
| Terminated | A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) NCT05160168 | Theseus Pharmaceuticals | Phase 1 / Phase 2 |
| Unknown | Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) M NCT05155215 | Beijing Immunochina Medical Science & Technology Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer NCT06926673 | GlaxoSmithKline | Phase 2 |
| Terminated | Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials NCT05100316 | GlaxoSmithKline | Phase 2 |
| Terminated | Mirtazapine in Cancer-related Poly-symptomatology NCT04763135 | Hospices Civils de Lyon | Phase 3 |
| Completed | Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands Duri NCT05022667 | University of Michigan | N/A |
| Active Not Recruiting | An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsore NCT05112965 | Hoffmann-La Roche | Phase 3 |
| Recruiting | Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors a NCT04572451 | Yana Najjar | Phase 1 |
| Completed | Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings NCT04931251 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Completed | The Effect of a Fasting MimickINg Diet on the Immune System NCT04833439 | Leiden University Medical Center | N/A |
| Completed | A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors NCT04991740 | Janssen Research & Development, LLC | Phase 1 |
| Recruiting | EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers NCT05176665 | Shanghai EpimAb Biotherapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tu NCT04958239 | Boehringer Ingelheim | Phase 1 |
| Completed | A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors NCT04991506 | Elpiscience Biopharma, Ltd. | Phase 1 |
| Recruiting | Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) NCT05066139 | Centre Paul Strauss | N/A |
| Recruiting | AnovaOS Network Powered Patient Registry NCT05013944 | Anova Enterprises, Inc | — |
| Unknown | VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK NCT04853303 | The Hong Kong Polytechnic University | N/A |
| Unknown | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor NCT04964375 | Abbisko Therapeutics Co, Ltd | Phase 1 |
| Unknown | 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical NCT04831307 | British Columbia Cancer Agency | N/A |
| Unknown | Dose Efficiency of Modern CT Scanners in Oncologic Scans NCT04989192 | University Hospital Augsburg | N/A |
| Completed | Oral Symptom Assessment Scale (OSAS): Validity and Reliability NCT04932317 | Our Lady's Hospice and Care Services | — |
| Completed | The Effect of Mindfulnes Program on Stress, Depression and Psychological Well-being in Cancer Patients NCT05187130 | Istanbul Aydın University | N/A |
| Terminated | (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC NCT04862780 | Blueprint Medicines Corporation | Phase 1 |
| Unknown | Smart Living Homes: GATEKEEPER System With Patients With Cancer and Dementia in Cyprus NCT05490524 | Cyprus University of Technology | N/A |
| Terminated | Molecular Disease Characterization Initiative (MDCI) NCT04772053 | GlaxoSmithKline | Phase 2 |
| Terminated | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic NCT04644315 | Hoffmann-La Roche | Phase 2 |
| Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 NCT04949282 | Sociedad Española de Medicina Nuclear e Imagen Molecular | — |
| Completed | Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers NCT05860530 | Qilu Pharmaceutical Co., Ltd. | N/A |
| Completed | High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy NCT04461509 | Alessandro D'Agnolo | Phase 2 |
| Completed | Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obs NCT06801405 | Barretos Cancer Hospital | — |
| Completed | A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors NCT04730843 | Elpiscience Biopharma, Ltd. | Phase 1 |
| Recruiting | A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors NCT04673942 | EpicentRx, Inc. | Phase 2 |
| Unknown | Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Canc NCT05912062 | Institut Català d'Oncologia | — |
| Completed | BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment NCT04932863 | Ente Ospedaliero Ospedali Galliera | — |
| Active Not Recruiting | CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood NCT04811846 | University Teaching Hospital Hall in Tirol | N/A |
| Terminated | Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round NCT06048705 | Adaptimmune | Phase 1 |
| Terminated | Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer NCT06790303 | GlaxoSmithKline | Phase 2 |
| Completed | Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Bi NCT04991805 | AstraZeneca | — |
| Completed | Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer NCT04724460 | Takeshi Morimoto | Phase 4 |
| Unknown | Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors NCT04787003 | North China Petroleum Bureau General Hospital | Phase 1 |
| Completed | PC001- A Study to Evaluate the Usability of PointCheck NCT04448301 | Leuko Labs, Inc. | N/A |
| Recruiting | Blood Cell RNA-Based Cancer Detection NCT05839834 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Completed | Intermittent Fasting and CLL/SLL NCT04626843 | Eleah Stringer | Phase 1 |
| Active Not Recruiting | Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer NCT04706676 | Rigshospitalet, Denmark | N/A |
| Completed | A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China NCT04722055 | Creative Biosciences (Guangzhou) Co., Ltd. | — |
| Completed | Information Needs Around Parenteral nUTrition in Cancer NCT04495530 | Royal Marsden NHS Foundation Trust | — |
| Recruiting | Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy NCT04746729 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Completed | Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in A NCT04596150 | CytomX Therapeutics | Phase 2 |
| Terminated | Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Li NCT05943990 | Adaptimmune | Phase 1 |
| Terminated | Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO- NCT04526509 | Adaptimmune | Phase 1 |
| Active Not Recruiting | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metasta NCT04607421 | Pfizer | Phase 3 |
| Active Not Recruiting | Anticoagulation in Patients With Venous Thromboembolism and Cancer NCT04618913 | Pfizer | — |
| Completed | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients NCT04604158 | Gillian Gresham | N/A |
| Unknown | External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patien NCT04697446 | Blueprint Medicines Corporation | — |
| Unknown | Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. NCT04388033 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 / Phase 2 |
| Completed | STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS NCT04635631 | Pfizer | Phase 1 |
| Completed | Mobile Sensor Technologies to Assess General Symptomology of People With Cancer NCT04465214 | National Cancer Institute (NCI) | — |
| Completed | Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial NCT04679675 | Kaiser Permanente | N/A |
| Active Not Recruiting | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation NCT04141449 | Brigham and Women's Hospital | Phase 2 |
| Active Not Recruiting | A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies NCT04606381 | Janssen Research & Development, LLC | Phase 1 |
| Unknown | Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian NCT04556071 | Xiaoxiang Chen | Phase 2 |
| Unknown | Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Un NCT05322486 | State Scientific Centre of Coloproctology, Russian Federation | — |
| Unknown | Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer NCT04566952 | Xiaoxiang Chen | Phase 2 |
| Completed | Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Ca NCT04442425 | National Cancer Institute (NCI) | — |
| Terminated | A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Ad NCT04349280 | GlaxoSmithKline | Phase 1 |
| Terminated | Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid NCT04544995 | GlaxoSmithKline | Phase 1 |
| Completed | Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatme NCT04568278 | Samsung Medical Center | N/A |
| Completed | Latest Imaging SPECT System Evaluation Phase 1 NCT04704349 | Centre Hospitalier Régional d'Orléans | N/A |
| Completed | An Evaluation of the Families Addressing Cancer Together (FACT) Intervention NCT04342871 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | Multimodal Program for Cancer Related Cachexia Prevention NCT04627376 | Cyprus University of Technology | N/A |
| Terminated | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic NCT04260802 | Ocellaris Pharma, Inc. | Phase 1 / Phase 2 |
| Unknown | Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk NCT04462926 | Azienda Ospedaliero-Universitaria di Modena | N/A |
| Active Not Recruiting | Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gas NCT05602935 | The Second Affiliated Hospital of Fujian Medical University | Phase 2 |
| Recruiting | ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling NCT04341181 | Ulrik Lassen | Phase 2 |
| Recruiting | Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Tria NCT04449549 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms NCT04509167 | Instituto de Medicina Regenerativa | EARLY_Phase 1 |
| Completed | A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients W NCT04147234 | Boehringer Ingelheim | Phase 1 |
| Terminated | A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer NCT04222972 | Hoffmann-La Roche | Phase 3 |
| Completed | Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients NCT04446416 | NaviFUS Corporation | N/A |
| Completed | Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma NCT04312737 | Hiantis Srl | — |
| Completed | A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers NCT04350463 | Celgene | Phase 2 |
| Completed | A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors NCT04397276 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt NCT04300179 | Assiut University | — |
| Completed | Clinical Evaluation of a Custom-made and Disposable Endoscope System for Biliary Tract NCT04456218 | National Cheng-Kung University Hospital | N/A |
| Recruiting | Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy NCT04442724 | Cedars-Sinai Medical Center | N/A |
| Active Not Recruiting | Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors NCT04446351 | GlaxoSmithKline | Phase 1 |
| Terminated | Continued Treatment for Participants Enrolled in Studies of BXQ-350 NCT04404569 | Bexion Pharmaceuticals, Inc. | Phase 1 |
| Not Yet Recruiting | Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma NCT03961841 | Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 |
| Recruiting | AIMS Cancer Outcomes Study NCT04495790 | Advanced Integrative Medical Science Institute | — |
| Unknown | Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma NCT04309084 | Celularity Incorporated | Phase 1 |
| Unknown | Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC NCT04371796 | Sichuan Cancer Hospital and Research Institute | Phase 2 |
| Unknown | ASCO Survey on COVID-19 in Oncology (ASCO) Registry NCT04659135 | American Society of Clinical Oncology | — |
| Unknown | The Effects of a 6-week Balance, Agility, Strengthening Exercise Class NCT04318574 | University of Manitoba | N/A |
| Terminated | Natural Killer Cell (CYNK-001) Infusions in Adults with AML NCT04310592 | Celularity Incorporated | Phase 1 |
| Active Not Recruiting | Effects of a Lay-led Anxiety and Depression Self-management Program for Cancer Patients NCT04537195 | University of Aarhus | N/A |
| Unknown | Identifying Novel Variants in the DPYD Gene in Patients of Non-Western Descent NCT04300361 | Leiden University Medical Center | — |
| Terminated | P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRP NCT04249947 | Poseida Therapeutics, Inc. | Phase 1 |
| Completed | Sexual & Gender Minority Competency in Oncology NCT04198090 | University of Rochester | N/A |
| Completed | Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose. NCT04288518 | Tomsk National Research Medical Center of the Russian Academy of Sciences | Phase 1 / Phase 2 |
| Completed | Study to Evaluate the Usability of PointCheck NCT04448314 | Leuko Labs, Inc. | — |
| Active Not Recruiting | M7824 Related Adverse Effects in Adults With Cancer NCT04267861 | National Cancer Institute (NCI) | — |
| Recruiting | A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With NCT05999994 | Eli Lilly and Company | Phase 2 |
| Recruiting | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid T NCT04192344 | Abbisko Therapeutics Co, Ltd | Phase 1 |
| Unknown | Improving the Safety of Fluoropyrimidine-based Chemotherapy NCT04194957 | The Netherlands Cancer Institute | N/A |
| Recruiting | LITT Followed by Hypofractionated RT for Recurrent Gliomas NCT04181684 | University of Maryland, Baltimore | N/A |
| Active Not Recruiting | Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 NCT06703346 | USWM CT, LLC | Phase 2 |
| Active Not Recruiting | Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 NCT05993299 | USWM, LLC (dba US WorldMeds) | Phase 2 |
| Active Not Recruiting | Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/ NCT03967223 | USWM CT, LLC | Phase 2 |
| Completed | A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread NCT04147247 | Boehringer Ingelheim | Phase 1 |
| Completed | A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Adva NCT04200963 | Ikena Oncology | Phase 1 |
| Terminated | A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced o NCT04157517 | Teva Branded Pharmaceutical Products R&D LLC | Phase 1 / Phase 2 |
| Completed | Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017 NCT04144842 | Alligator Bioscience AB | Phase 1 |
| Terminated | SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Meta NCT03694015 | British Columbia Cancer Agency | N/A |
| Unknown | A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors NCT04151186 | suhaichuan | N/A |